Researchers know that children born to mothers who have depression in pregnancy are at risk for developmental delays but haven’t known why. Now, a National Institutes of Health study suggests that depression persisting after pregnancy and reduced breastfeeding may account for at least part of the increased risk. Based on their results, researchers conclude that physicians may be able to reduce this risk by offering treatment for depression both during and after pregnancy and by counseling new mothers on how to breastfeed successfully.
News
NICHD issues News Releases and Media Advisories to the news media. Spotlight and Research Feature articles explain NICHD research findings and public health issues to the general public. An Item of Interest is a short announcement of relevant information, such as a notable staff change.
Science Update: Compound in olive leaves may provide endometriosis treatment, NIH-funded mouse study suggests
Oleuropein, a compound found in olive oil and olive leaves, may have the potential to treat endometriosis with fewer side effects than current treatments, suggests a study of mice and human tissue cultures funded by the National Institutes of Health.
Director's Corner: Reflecting on NICHD’s 60th Anniversary Year
Research conducted at NICHD and at NICHD-funded institutions continues to bring us closer to fulfilling our vision of ensuring healthy pregnancies, healthy children, and healthy and optimal lives.
Selected NICHD Research Advances of 2022
Read about NICHD’s research findings and activities from 2022.
Science Update: NIH-funded researchers examine uterine prolapse surgical trial outcomes
Study finds that a second operation benefits the small subset of women who choose reoperation for recurring symptoms.
Science Update: Common chemical may promote fibroid growth, small NIH-funded study suggests
Exposure to a chemical found in a wide variety of consumer products may trigger the growth of uterine fibroid cells and delay the rate at which they die, suggests a study
funded by the National Institutes of Health. The study provides a potential explanation for why women exposed to industrial chemicals known as phthalates—found in personal care products, food packaging, and medical products—have higher rates of fibroid tumors than other women. The findings may also inform future strategies to prevent or treat fibroids.
Media Advisory: NIH-funded researchers to begin study of intravenous iron treatment for post-pregnancy anemia
Researchers supported by the National Institutes of Health are launching a large study to evaluate a single dose of intravenous iron to treat women experiencing anemia
after giving birth. The study will enroll nearly 5,000 women in Bangladesh, India, Pakistan, the Democratic Republic of Congo, Kenya, Zambia and Guatemala.
Media Advisory: No increase in risk of serious pregnancy complications during early pandemic, NIH-funded study suggests
Compared to giving birth in 2019, giving birth in 2020 during the early stages of the pandemic was not associated with a higher risk of maternal death or a serious complication of pregnancy, suggests a study funded by the National Institutes of Health.
Science Update: Placental malaria may slow glucose flow to the fetus, NIH-funded study suggests
Malaria infection of the placenta may reduce the amount of glucose that passes to the fetus, according to an NIH-funded study. The research involves a placenta on a chip model—a laboratory device incorporating placental tissue to simulate the interface between maternal blood and the outermost part of the placenta. The findings offer insight into how placental malaria may deprive the fetus of an essential nutrient and may inform the development of strategies to prevent or treat the condition.
Science Update: NIH-led working group proposes new paradigm of ovarian anatomy
A group of experts led by NICHD has proposed a new anatomic model of the ovary and recommended standardized nomenclature to describe its major features.
Release: Study confirms link between COVID-19 vaccination and temporary increase in menstrual cycle length
A large international study has confirmed the findings of a previous U.S. study that linked COVID-19 vaccination with an average increase in menstrual cycle length of less than one day. The increase was not associated with any change in the number of days of menses (days of bleeding). Funded by the National Institutes of Health, the new study included data from nearly 20,000 people from Canada, the United Kingdom, the United States, Europe and other parts of the world who received any of nine different vaccines. For most study participants, the increase resolved in the cycle following vaccination.
Science Update: Pregnancy-associated homicides on the rise in the United States, suggests NICHD-funded study
U.S. rates of pregnancy-associated homicide—deaths that occur among women who are pregnant or had been pregnant within one year—rose in 2020 during the COVID-19 pandemic, according to a recent NICHD-funded study.
Director's Corner: Crowdsourcing to Advance Maternal Health Research
Challenge competitions offer a mechanism to quickly bring in diverse voices and expertise to innovate and problem-solve. This month, NICHD and partners launched two challenges focused on improving our nation’s maternal health: the RADx® Tech for Maternal Health Challenge and the Connecting the Community for
Maternal Health Challenge.
Release: NIH launches $8 million prize competition to reduce maternal deaths in regions that lack maternity care
The National Institutes of Health is offering up to $8 million in cash prizes to accelerate development of technologies to improve maternal health outcomes for those who live in areas lacking access to maternity care.
Release: NIH launches challenge to advance community-based maternal health research
The National Institutes of Health has launched a $3 million challenge competition to encourage community-based and advocacy organizations in the United States to develop the infrastructure and capabilities necessary to conduct maternal health research.
Item of Interest: NIH to establish Maternal Health Research Centers of Excellence
NIH recently released three funding opportunity announcements inviting applications for the Maternal Health Research Centers of Excellence initiative, which will develop and evaluate innovative approaches to reduce pregnancy-related complications and deaths and promote maternal health equity.
Spotlight: One year and counting: Male birth control study reaches milestone
Learn about an experimental male contracteptive gel called NES/T, which was developed in collaboration with NICHD and the Population Council.
Science Update: Endometriosis linked to higher stroke risk, NIH-funded study suggests
Women with endometriosis may have a higher risk for stroke, suggests a study funded by the National Institutes of Health. The analysis of more than 110,000 women found that compared to women without the condition, women who had been diagnosed with endometriosis had a 34% higher risk for stroke. The study authors concluded that physicians should consider counseling patients with endometriosis about their risk for stroke and other cardiovascular conditions.
Science Update: Pregnant people with disabilities at higher risk for intimate partner violence, NIH-funded study suggests
Compared to pregnant people without a disability, pregnant people with disabilities may have about two and a half times the risk of experiencing intimate partner violence in the year before pregnancy and during pregnancy, suggests a study funded by the National Institutes of Health. The study authors conclude that health care providers should be vigilant in screening persons with disabilities for intimate partner violence before and during pregnancy and refer them to appropriate information and resources.
Science Update: Hormone prevents obesity in offspring of pregnant mice with obesity, according to NIH-funded study
Giving the hormone adiponectin to pregnant mice with obesity prevented later life obesity and related health conditions in their offspring, according to a study funded by the National Institutes of Health. The findings suggest that adiponectin, a hormone produced by fat cells, could play a role in reducing the lifelong obesity risk of children born to mothers with obesity during pregnancy.